FDA 483 - RedPharm Drug - August 01, 2025

RedPharm Drug Inc, a repackaging firm in Eden Prairie, MN, was cited for three observations during an FDA inspection. The findings indicate deficiencies in the quality control unit's oversight of contract repackers, incomplete documentation for returned drug products, and inadequate GMP training for distribution and packaging personnel. These issues suggest a lack of robust quality system controls and personnel training.